Search for Clinical Trial Results
Gaucher Disease - 63 Studies Found
Status | Study |
Completed |
Study Name: Study to Evaluate Blood Cell Lines From Patients With Gaucher Disease Condition: Gaucher Disease Date: 2006-07-10 Interventions: Procedure: Blood sample |
Completed |
Study Name: Effects of Enzyme Replacement in Gaucher's Disease Condition: Gaucher's Disease Date: 1999-11-03 |
Not yet recruiting |
Study Name: Pharmacokinetics, Pharmacodynamics And Safety Study Of Elelyso(tm) In Pediatric Subjects With Type 1 Gaucher Disease Condition: Type 1 Gaucher Disease Date: 2016-09-23 Interventions: Drug: Elelyso 60 units/kg All patients receive Elelyso 60 units/kg. |
Suspended |
Study Name: Clinical Trial of Ambroxol in Patients With Type I Gaucher Disease Condition: Type I Gaucher Disease Date: 2011-10-27 Interventions: Drug: Ambroxol Ambroxol at a dose level of 187.5 or 225 mg/day will be given once daily by mouth for 2 m |
Recruiting |
Study Name: Role of Oxidative Stress and Inflammation in Type 1 Gaucher Disease (GD1) Condition: Gaucher Disease Type 1 Date: 2015-08-21 Interventions: Drug: N-acetylcysteine 1800mg NAC twice daily (3600mg/day) orally for approximately 90 days. |
Completed |
Study Name: PEG-Glucocerebrosidase for the Treatment of Gaucher Disease Condition: Gaucher's Disease Date: 1999-11-03 Interventions: Drug: Lysodase |
Completed |
Study Name: A Study to Evaluate and Characterize the Effect of Pharmacological Chemicals on Blood From Patients With Gaucher Disease Condition: Gaucher Disease Date: 2007-04-21 |
No longer available |
Study Name: Expanded Access Trial of Plant Expressed Recombinant Glucocerebrosidase (prGCD) in Patients With Gaucher Disease Condition: Gaucher Disease Date: 2009-08-18 Interventions: Drug: Plant cell expressed recombinant glucocerebrosidase (prGCD) Intravenous infusion every two weeks a |
Completed |
Study Name: OGT 918-006: A Phase I/II Randomized, Controlled Study of OGT 918 in Patients With Neuronopathic Gaucher Disease Condition: Gaucher Disease Date: 2002-07-09 Interventions: Drug: OGT 918 |
Recruiting |
Study Name: Home Therapy With VPRIV in Gaucher's Disease Condition: Gaucher Disease Date: 2011-05-17 |